![Mechanism of Antigen Presentation and Specificity of Antibody Cross- Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine Mechanism of Antigen Presentation and Specificity of Antibody Cross- Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine](https://www.genomics.sinica.edu.tw/media/k2/items/cache/1e6006496cec394e7da669516f53f970_XL.jpg?t=20240410_060242)
Mechanism of Antigen Presentation and Specificity of Antibody Cross- Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![Aqueous two-phase system patterning of detection antibody solutions for cross-reaction-free multiplex ELISA | Scientific Reports Aqueous two-phase system patterning of detection antibody solutions for cross-reaction-free multiplex ELISA | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep04878/MediaObjects/41598_2014_Article_BFsrep04878_Fig1_HTML.jpg)
Aqueous two-phase system patterning of detection antibody solutions for cross-reaction-free multiplex ELISA | Scientific Reports
![Antibody cross-reactivity accounts for widespread appearance of m1A in 5'UTRs | Nature Communications Antibody cross-reactivity accounts for widespread appearance of m1A in 5'UTRs | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-13146-w/MediaObjects/41467_2019_13146_Fig1_HTML.png)
Antibody cross-reactivity accounts for widespread appearance of m1A in 5'UTRs | Nature Communications
![Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12026-012-8268-8/MediaObjects/12026_2012_8268_Fig2_HTML.gif)
Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research
![Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1367593113002317-gr1.jpg)
Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing - ScienceDirect
![Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12026-012-8268-8/MediaObjects/12026_2012_8268_Fig1_HTML.gif)
Human poly- and cross-reactive anti-viral antibodies and their impact on protection and pathology | Immunologic Research
![Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121001567-fx1.jpg)
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions - ScienceDirect
![Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/03/18/2020.03.17.995738/F1.large.jpg)
Repurposing Old Antibodies for New Diseases by Exploiting Cross Reactivity and Multicolored Nanoparticles | bioRxiv
![Frontiers | Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases Frontiers | Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases](https://www.frontiersin.org/files/Articles/617089/fimmu-11-617089-HTML/image_m/fimmu-11-617089-g007.jpg)